Dr. Kopp is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3303 S Bond Ave
Ste CH10U
Portland, OR 97239Phone+1 503-494-4779
Summary
- Dr. Ryan Kopp is an urologist in Portland, OR and is affiliated with VA Portland Healthcare System. He received his medical degree from Indiana University School of Medicine, residency training at UC San Diego, and completed his urologic oncology fellowship at Memorial Sloan Kettering Cancer Center. He has held an appointment at Oregon Health & Science University and the VA Portland Healthcare System since 2015. He specializes in urologic oncology and is experienced in multidisciplinary care of genitourinary cancers (prostate, kidney, testicular, bladder), genetic research, cancer early detection, and clinical trials.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Urologic Surgical Oncology, 2013 - 2015
University of California (San Diego) Medical CenterResidency, Urology, 2009 - 2013- University of California (San Diego) Medical CenterResidency, Surgery, 2007 - 2009
Indiana University School of MedicineClass of 2007
Certifications & Licensure
OR State Medical License 2015 - 2025
NY State Medical License 2012 - 2016
CA State Medical License 2009 - 2013- American Board of Urology Urology
Clinical Trials
- A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss Start of enrollment: 2024 May 31
- S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer Start of enrollment: 2017 Feb 24
- Safety and Pharmacology Study of Atezolizumab Alone and in Combination With Bacille Calmette-Guérin (BCG) in High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Participants Start of enrollment: 2016 Jun 13
- Join now to see all
Publications & Presentations
PubMed
- 379 citationsPeroxisome Proliferator-activated Receptor Coactivator-1α (PGC-1α) Coactivates the Cardiac-enriched Nuclear Receptors Estrogen-related Receptor-α and -γ IDENTIFICATION...Janice M. Huss, Ryan P. Kopp, Daniel P. Kelly
The Journal of Biological Chemistry. 2002-10-25 - 71 citationsFeasibility and efficacy of neoadjuvant sunitinib before nephron‐sparing surgeryJonathan L. Silberstein, Frederick Millard, Reza Mehrazin, Ryan Kopp, Wassim M. Bazzi
BJU International. 2010-11-01 - 12 citationsEpigenetic loss of heterogeneity from low to high grade localized prostate tumours.Sebnem Ece Eksi, Alex Chitsazan, Zeynep Sayar, George V Thomas, Andrew J Fields
Nature Communications. 2021-12-15
Grant Support
- Integration of Magnetic Resonance Imaging and Protein Biomarkers for Identification of Aggressive Prostate CancerCDMRP Prostate Cancer Research ProgramPresent
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
